BAGSVAERD, DENMARK--(Marketwired - April 22, 2013) - At Novo Nordisk's Annual General Meeting
20 March 2013, it was decided to reduce the company's B share capital from
452,512,800 to DKK 442,512,800 by cancellation of part of the company's
portfolio of own B shares at a nominal value of DKK 10,000,000 divided into
10,000,000 B shares of DKK 1 each.
Articles of Association of Novo Nordisk A/S:
Company announcement No 28 / 2013:
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Novo Nordisk A/S via Thomson Reuters ONE